NTRA Natera Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NTRA

Price (delayed)

$390.79

Market cap

$56.33B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.35

Enterprise value

$55.46B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 37

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of ...

Highlights
NTRA's equity is up by 46% year-on-year and by 2.7% since the previous quarter
Natera's gross profit has increased by 43% YoY and by 9% QoQ
The company's debt rose by 22% YoY
The quick ratio has declined by 20% year-on-year
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.natera.com
Peers: PRTA VRTX ARDX EBS

Key stats

What are the main financial stats of NTRA

NTRA stock price

How has the Natera stock price performed over time
Intraday
-0.03%
1 week
13.16%
1 month
17.7%
1 year
126.11%
YTD
70.58%
QTD
43.96%

Financial performance

How have Natera's revenue and profit performed over time
Revenue
$2.71B
Gross profit
$1.77B
Operating income
-$289.67M
Net income
-$192.35M
Gross margin
65.2%
Net margin
-7.1%
The company's net margin rose by 45% YoY and by 21% QoQ
Natera's gross profit has increased by 43% YoY and by 9% QoQ
NTRA's revenue is up by 38% year-on-year and by 8% since the previous quarter
NTRA's operating margin is up by 28% year-on-year and by 18% since the previous quarter

Price vs fundamentals

How does NTRA's price correlate with its fundamentals

Growth

What is Natera's growth rate over time

Valuation

What is Natera stock price valuation
P/E
N/A
P/B
30.73
P/S
20.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
20.49
The EPS has increased by 29% YoY and by 17% from the previous quarter
The stock's P/B is 129% more than its 5-year quarterly average of 13.4 and 67% more than its last 4 quarters average of 18.4
NTRA's equity is up by 46% year-on-year and by 2.7% since the previous quarter
NTRA's price to sales (P/S) is 118% higher than its 5-year quarterly average of 9.5 and 67% higher than its last 4 quarters average of 12.4
NTRA's revenue is up by 38% year-on-year and by 8% since the previous quarter

Efficiency

How efficient is Natera business performance
The ROE has grown by 47% YoY and by 23% from the previous quarter
The ROA is up by 46% year-on-year and by 23% since the previous quarter
The ROS has increased by 27% YoY and by 19% from the previous quarter
The return on invested capital has increased by 18% since the previous quarter

Dividends

What is NTRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NTRA.

Financial health

How did Natera financials performed over time
NTRA's total liabilities has surged by 64% year-on-year
NTRA's total assets has soared by 51% YoY
The company's debt is 88% lower than its equity
NTRA's equity is up by 46% year-on-year and by 2.7% since the previous quarter
The company's debt rose by 22% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.